pharma Β· Pyruvate Kinase Deficiency Β· Sickle Cell Disease Β· AGIO
Agios Netherlands
Agios Netherlands B.V.
Agios Netherlands trial registry β 51 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- CAMBRIDGE, MA, NL
- Founded
- 1978
- Employees
- 20
- Programs
- 45
- Drugs
- 15
- Patents
- 93
Agios Netherlands clinical trials
Registry index of 51 ClinicalTrials.gov studies linked to Agios Netherlands programs β each row shows trial ID, program name, phase, status, and indication.
Agios Netherlands trial registry β 51 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Agios Netherlands.
-
Placebo Matching Mitapivat β Phase 3
Clinical update -
Mitapivat β Phase 3
Clinical update -
Mitapivat β Approved
Clinical update -
Mitapivat β Phase 3
Clinical update -
Mitapivat β Phase 3
Clinical update -
Mitapivat β Phase 1
Clinical update -
Mitapivat β Phase 1
Clinical update -
Mitapivat β Phase 2
Clinical update
Trial registry
-
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β